XML 38 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
11. Segment Information
 9 Months Ended
Sep. 30, 2015
Segment Reporting [Abstract]  
Segment Information
11.    SEGMENT INFORMATION

Information regarding industry segments for the three months ended September 30, 2015 and 2014 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2015
$
150.4

 
$
316.2

 
$
3.4

 
2014
$
172.8

 
$
354.7

 
$
3.1

 
 
 
 
 
 
 
Segment net (loss) profit
2015
$
(12.3
)
 
$
40.2

 
$
0.4

 
2014
$
(10.6
)
 
$
47.8

 
$
0.1


Information regarding industry segments for the nine months ended September 30, 2015 and 2014 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2015
$
476.8

 
$
961.9

 
$
10.2

 
2014
$
504.6

 
$
1,062.0

 
$
10.2

 
 
 
 
 
 
 
Segment net (loss) profit
2015
$
(20.4
)
 
$
116.3

 
$
0.2

 
2014
$
(24.5
)
 
$
130.3

 
$
0.4



Segment results are presented in the same manner as we present our operations internally to make operating decisions and assess performance.  Net corporate operating, interest and other expense for segment results consists of receipts and expenditures that are not the primary responsibility of segment operating management and therefore are not allocated to the segments for performance assessment by our chief operating decision maker.  During the three and nine months ended September 30, 2014, these expenses included an accrual of $12.1 million and $20.1 million, respectively, associated with the U.S. Securities and Exchange Commission (SEC) and Department of Justice (DOJ) investigations relating to the U.S. Foreign Corrupt Practices Act (FCPA), for which a final settlement was reached in the fourth quarter of 2014. Interest expense is charged to segments based on the carrying amount of inventory and receivables employed by that segment.  The following reconciles total segment profit to consolidated income before taxes (in millions):

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2015
 
2014
 
2015
 
2014
Total segment profit
$
28.3

 
$
37.3

 
$
96.1

 
$
106.2

Foreign currency exchange losses, net
(2.2
)
 
(3.7
)
 
(8.9
)
 
(6.1
)
Net corporate operating, interest and other expense not allocated to segments
(1.4
)
 
(11.7
)
 
(4.6
)
 
(24.0
)
Other income (expense), net
0.7

 
0.6

 
9.0

 
9.7

Consolidated income before income taxes
$
25.4

 
$
22.5

 
$
91.6

 
$
85.8